BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320. [PMID: 8360967 DOI: 10.1001/jama.1993.03510110056031] [Cited by in Crossref: 223] [Cited by in F6Publishing: 161] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Geh J. The use of chemoradiotherapy in oesophageal cancer. European Journal of Cancer 2002;38:300-13. [DOI: 10.1016/s0959-8049(01)00353-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
2 Kiesslich R. Le bleu de méthylène facilite le diagnostic de l’épithélium intestinal spécialisé. Acta Endosc 2001;31:141-9. [DOI: 10.1007/bf03023601] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Fisher OM, Levert-Mignon AJ, Lehane CW, Botelho NK, Maag JL, Thomas ML, Edwards M, Lord SJ, Bobryshev YV, Whiteman DC, Lord RV. CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy. Ann Surg Oncol 2016;23:746-54. [PMID: 27577713 DOI: 10.1245/s10434-016-5504-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Peng D, Sheta EA, Powell SM, Moskaluk CA, Washington K, Goldknopf IL, El-Rifai W. Alterations in Barrett's-related adenocarcinomas: a proteomic approach. Int J Cancer 2008;122:1303-10. [PMID: 18000824 DOI: 10.1002/ijc.23258] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
5 Poneros JM. Diagnosis of Barrett's esophagus using optical coherence tomography. Gastrointest Endosc Clin N Am. 2004;14:573-88, x. [PMID: 15261203 DOI: 10.1016/j.giec.2004.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
6 Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointestinal Endoscopy 1996;44:532-5. [DOI: 10.1016/s0016-5107(96)70004-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
7 Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc. 1999;50:23-26. [PMID: 10385717 DOI: 10.1016/s0016-5107(99)70339-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
8 Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD. Pathologic prognostic factors in Barrett's-associated adenocarcinoma: A follow-up study of 96 patients. Cancer 1999;85:520-8. [DOI: 10.1002/(sici)1097-0142(19990201)85:3<520::aid-cncr2>3.0.co;2-l] [Cited by in Crossref: 36] [Article Influence: 1.6] [Reference Citation Analysis]
9 Wall CM, Charlett A, Caygill CP, Gatenby PA, Ramus JR, Winslet MC, Watson A. Are newly diagnosed columnar-lined oesophagus patients getting younger? Eur J Gastroenterol Hepatol. 2009;21:1127-1131. [PMID: 19295439 DOI: 10.1097/meg.0b013e328329c414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Musana AK, Resnick JM, Torbey CF, Mukesh BN, Greenlee RT. Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. Am J Gastroenterol 2008;103:516-24. [PMID: 17970839 DOI: 10.1111/j.1572-0241.2007.01599.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
11 Dlamini Z, Raidoo D, Bhoola K. Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology 1999;43:303-10. [DOI: 10.1016/s0162-3109(99)00101-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Powell EL, Leoni LM, Canto MI, Forastiere AA, Iocobuzio-Donahue CA, Wang JS, Maitra A, Montgomery E. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol 2005;29:1497-504. [PMID: 16224217 DOI: 10.1097/01.pas.0000170349.47680.e8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
13 Mokrowiecka A, Veits L, Falkeis C, Musial J, Kordek R, Lochowski M, Kozak J, Wierzchniewska-Lawska A, Vieth M, Malecka-Panas E. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Pathol Res Pract. 2017;213:205-209. [PMID: 28216140 DOI: 10.1016/j.prp.2016.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
14 Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, Liff JM, Schwartz AG, Hayes RB, Blot WJ. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control. 1994;5:333-340. [PMID: 8080945 DOI: 10.1007/bf01804984] [Cited by in Crossref: 135] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
15 Carucci LR, Turner MA. Dysphagia revisited: common and unusual causes. Radiographics 2015;35:105-22. [PMID: 25590391 DOI: 10.1148/rg.351130150] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
16 Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008;123:1422-1428. [PMID: 18546259 DOI: 10.1002/ijc.23691] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 9.4] [Reference Citation Analysis]
17 Kearney DJ, Crump C, Maynard C, Boyko EJ. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD. Gastrointest Endosc 2003;57:823-9. [PMID: 12776027 DOI: 10.1016/s0016-5107(03)70015-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
18 Landreneau RJ, Wiechmann RJ, Hazelrigg SR, Santucci TS, Boley TM, Magee MJ, Naunheim KS. Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg 1998;66:1886-93. [PMID: 9930464 DOI: 10.1016/s0003-4975(98)01260-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
20 Shepherd NA. La dysplasie dans l’œsophage de Barrett. Acta Endosc 2000;30:123-32. [DOI: 10.1007/bf03022279] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
21 Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151-159. [PMID: 16299786 DOI: 10.1002/jso.20357] [Cited by in Crossref: 216] [Cited by in F6Publishing: 189] [Article Influence: 12.7] [Reference Citation Analysis]
22 Omae M, Fujisaki J, Horiuchi Y, Yoshizawa N, Matsuo Y, Kubota M, Suganuma T, Okada K, Ishiyama A, Hirasawa T, Yamamoto Y, Tsuchida T, Hoshino E, Igarashi M. Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer 2013;16:147-54. [PMID: 22692465 DOI: 10.1007/s10120-012-0162-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
23 Huang Q, Shi J, Sun Q, Fan X, Feng A, Wu H, Zhou Q, Yu C, Mashimo H, Lauwers GY. Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare. Hum Pathol. 2012;43:2138-2148. [PMID: 22658274 DOI: 10.1016/j.humpath.2012.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
24 Spechler SJ. Esophageal Columnar Metaplasia (Barrett’s Esophagus). Gastrointestinal Endoscopy Clinics of North America 1997;7:1-18. [DOI: 10.1016/s1052-5157(18)30319-2] [Cited by in Crossref: 18] [Article Influence: 0.7] [Reference Citation Analysis]
25 Levine MS, Halvorsen RA. Carcinoma of the Esophagus. Textbook of Gastrointestinal Radiology. Elsevier; 2008. pp. 417-46. [DOI: 10.1016/b978-1-4160-2332-6.50032-4] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
26 Polkowski W, van Sandick JW, Offerhaus GJA, ten Kate FJW, Mulder J, Obertop H, van Lanschot JJB. Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction. Ann Surg Oncol 1999;6:290-7. [DOI: 10.1007/s10434-999-0290-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
27 Reynolds JC. Innovative endoscopic mapping technique of barrett’s mucosa. The American Journal of Medicine 2001;111:142-6. [DOI: 10.1016/s0002-9343(01)00865-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
28 Kubo A, Corley DA, Jensen CD, Kaur R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev. 2010;23:230-246. [PMID: 20624335 DOI: 10.1017/s0954422410000132] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
29 Tan BH, Skipworth RJ, Stephens NA, Wheelhouse NM, Gilmour H, de Beaux AC, Paterson-Brown S, Fearon KC, Ross JA. Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett’s oesophagus. Eur J Cancer. 2009;45:736-740. [PMID: 19211242 DOI: 10.1016/j.ejca.2009.01.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
30 Mörk H, Al-Taie O, Berlin F, Kraus MR, Scheurlen M. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation. Scand J Gastroenterol. 2007;42:23-27. [PMID: 17190758 DOI: 10.1080/00365520600825125] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
31 Wei X, Chen Z, Yang X, Wu T. Chinese herbal medicines for esophageal cancer. Cochrane Database Syst Rev 2009;:CD004520. [PMID: 19821327 DOI: 10.1002/14651858.CD004520.pub6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 Souza RF, Spechler SJ. Barrett's esophagus: chemoprevention. Gastrointestinal Endoscopy Clinics of North America 2003;13:419-32. [DOI: 10.1016/s1052-5157(03)00039-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Eisen GM, Dominitz JA, Faigel DO, Goldstein JL, Kalloo AN, Petersen BT, Raddawi HM, Ryan ME, Vargo JJ, Young HS, Fanelli RD, Hyman NH, Wheeler-harbaugh J. Ethnic issues in endoscopy. Gastrointestinal Endoscopy 2001;53:874-5. [DOI: 10.1016/s0016-5107(01)70310-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Soest EMV, Dieleman JP, Kuipers EJ. The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders. Expert Opinion on Drug Safety 2008;7:173-80. [DOI: 10.1517/14740338.7.2.173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
35 Levi F, Randimbison L, Lucchini F, Te V, La Vecchia C. Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus: . European Journal of Cancer Prevention 2001;10:91-6. [DOI: 10.1097/00008469-200102000-00011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
36 Parkin D, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. European Journal of Cancer 2001;37:4-66. [DOI: 10.1016/s0959-8049(01)00267-2] [Cited by in Crossref: 1284] [Cited by in F6Publishing: 457] [Article Influence: 61.1] [Reference Citation Analysis]
37 Westhoff B, Brotze S, Weston A, McElhinney C, Cherian R, Mayo MS, Smith HJ, Sharma P. The frequency of Barrett’s esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226-231. [PMID: 15729230 DOI: 10.1016/s0016-5107(04)02589-1] [Cited by in Crossref: 113] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
38 Liu L, Ergun G, Ertan A, Woods K, Sachs I, Younes M. Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring: OXIDATIVE DNA DAMAGE AND pH MONITORING IN OESOPHAGEAL REFLUX. Alimentary Pharmacology & Therapeutics 2003;18:693-8. [DOI: 10.1046/j.1365-2036.2003.01734.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
39 Souza RF. Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma. Surg Oncol Clin N Am 2002;11:257-72, viii. [PMID: 12424849 DOI: 10.1016/s1055-3207(02)00003-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
40 Xu X, LoCicero J, Macri E, Loda M, Ellis FH. Barrett’s esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res. 2000;88:120-124. [PMID: 10644476 DOI: 10.1006/jsre.1999.5774] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
41 Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: Mature results of phase II study. International Journal of Radiation Oncology*Biology*Physics 2004;60:111-22. [DOI: 10.1016/j.ijrobp.2004.03.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
42 Gross CP, Canto MI, Hixson J, Powe NR. Management of Barrett's Esophagus: A National Study of Practice Patterns and Their Cost Implications. American Journal of Gastroenterology 1999;94:3440-7. [DOI: 10.1111/j.1572-0241.1999.01606.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
43 Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-955; discussion 955-956. [PMID: 9434690 DOI: 10.1016/s0022-5223(97)70009-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
44 Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas. Am J Surg Pathol. 2007;31:569-575. [PMID: 17414104 DOI: 10.1097/01.pas.0000213394.34451.d2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
45 Stamp D. Bile acids and esophageal cancer the elusive "pulsatile acid or bile acid-induced" proliferation. Med Hypotheses 2010;75:338-40. [PMID: 20427131 DOI: 10.1016/j.mehy.2010.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Johnson MC. The esophagus. Primary Care: Clinics in Office Practice 2001;28:459-85. [DOI: 10.1016/s0095-4543(05)70048-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
47 Spechler SJ. Barrett's oesophagus: diagnosis and management. Best Practice & Research Clinical Gastroenterology 2000;14:857-79. [DOI: 10.1053/bega.2000.0129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Baloch Z, Lyle S, Hoda RS, Gupta PK. Ultrasound-guided fine-needle aspiration diagnosis of adenocarcinoma of esophagus with signet-ring cell features arising in Barrett's esophagus: A case report. Diagn Cytopathol 1998;19:51-4. [DOI: 10.1002/(sici)1097-0339(199807)19:1<51::aid-dc10>3.0.co;2-7] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
49 Tran B, Lucas R, Kimlin M, Whiteman D, Neale R; Australian Cancer Study. Association between ambient ultraviolet radiation and risk of esophageal cancer. Am J Gastroenterol. 2012;107:1803-1813. [PMID: 23032986 DOI: 10.1038/ajg.2012.329] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
50 Ribeiro U, Finkelstein SD, Safatle-ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998;83:7-18. [DOI: 10.1002/(sici)1097-0142(19980701)83:1<7::aid-cncr2>3.0.co;2-r] [Cited by in Crossref: 98] [Article Influence: 4.1] [Reference Citation Analysis]
51 Stamp DH. Bile acids aided by acid suppression therapy may be associated with the development of esophageal cancers in westernized societies. Medical Hypotheses 2006;66:154-7. [DOI: 10.1016/j.mehy.2005.04.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
52 Brock MV, Are C, Wu T, Canto M, Yang SC, Heitmiller RF. Polypoid esophageal adenocarcinoma—a clinicopathological variant of esophageal cancer? Current Surgery 2002;59:336-41. [DOI: 10.1016/s0149-7944(01)00598-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg. 2001;88:338-356. [PMID: 11260097 DOI: 10.1046/j.1365-2168.2001.01670.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 130] [Article Influence: 6.9] [Reference Citation Analysis]
54 Montgomery E, Mamelak AJ, Gibson M, Maitra A, Sheikh S, Amr SS, Yang S, Brock M, Forastiere A, Zhang S, Murphy KM, Berg KD. Overexpression of Claudin Proteins in Esophageal Adenocarcinoma and Its Precursor Lesions. Applied Immunohistochemistry & Molecular Morphology 2006;14:24-30. [DOI: 10.1097/01.pai.0000151933.04800.1c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
55 Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001;54:689-696. [PMID: 11726843 DOI: 10.1067/mge.2001.119216] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 5.0] [Reference Citation Analysis]
56 Patti MG, Owen D. Prognostic Factors in Esophageal Cancer. Surgical Oncology Clinics of North America 1997;6:515-31. [DOI: 10.1016/s1055-3207(18)30315-6] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
57 Gao SG, Wang LD, Fan ZM, Li JL, He X, Guo RF, Xie DL, He XW, Gao SS, Guo HQ, Wang JK, Feng XS, Ma BG. Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol 2005; 11(30): 4634-4637 [PMID: 16094701 DOI: 10.3748/wjg.v11.i30.4634] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Seung SK, Smith JW, Ross HJ. Selective dose escalation of chemoradiotherapy for locally advanced esophageal cancer. Diseases of the Esophagus 2008;21:589-95. [DOI: 10.1111/j.1442-2050.2008.00822.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy 1999;50:229-40. [DOI: 10.1016/s0016-5107(99)70230-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
60 Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: Clinical relevance and ambulatory detection: BILE IN THE OESOPHAGUS. Br J Surg 1997;84:21-8. [DOI: 10.1046/j.1365-2168.1997.02648.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Chen X, Deng L, Jiang X, Wu T. Chinese herbal medicine for oesophageal cancer. Cochrane Database Syst Rev 2016;:CD004520. [PMID: 26799001 DOI: 10.1002/14651858.CD004520.pub7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
62 Levi F, Randimbison L, La Vecchia C. Esophageal and gastric carcinoma in Vaud, Switzerland, 1976-1994. Int J Cancer 1998;75:160-1. [DOI: 10.1002/(sici)1097-0215(19980105)75:1<160::aid-ijc25>3.0.co;2-j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
63 Archer V, Mulholland P, Stocken D, Darnton S, Ferry D. Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus. Clinical Oncology 2001;13:164-9. [DOI: 10.1053/clon.2001.9246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
64 Ashfaq A, Kidwell JT, McGhan LJ, Dueck AC, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of a gastric cancer nomogram using a cancer registry. J Surg Oncol 2015;112:377-80. [PMID: 26271201 DOI: 10.1002/jso.23999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
65 Guo W, Ma Z, Zhao YP, Jiang YG. Controllable metastasis: the trap for the esophageal cancer cells? Med Hypotheses 2010;74:1000-1. [PMID: 20129740 DOI: 10.1016/j.mehy.2010.01.017] [Reference Citation Analysis]
66 Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, Hawes RH, Wallace MB. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc 2003;57:311-8. [PMID: 12612508 DOI: 10.1067/mge.2003.101] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
67 Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53. [DOI: 10.1002/(sici)1097-0142(19981115)83:10<2049::aid-cncr1>3.0.co;2-2] [Cited by in Crossref: 1358] [Cited by in F6Publishing: 2] [Article Influence: 56.6] [Reference Citation Analysis]
68 Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795-1800. [PMID: 12269973 DOI: 10.1046/j.1365-2036.2002.01351.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 6.0] [Reference Citation Analysis]
69 Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 1999;49:170-176. [PMID: 9925694 DOI: 10.1016/s0016-5107(99)70482-7] [Cited by in Crossref: 201] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
70 Petrakis IE, Sciacca V, Iascone C. Diagnosis and Treatment of Barrett’s Oesophagus. A General Survey. Acta Chirurgica Belgica 2001;101:53-8. [DOI: 10.1080/00015458.2001.12098586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Aldulaimi DM, Cox M, Nwokolo CU, Loft DE. Barrett’s surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol. 2005;17:943-950. [PMID: 16093872 DOI: 10.1097/00042737-200509000-00010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
72 Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastroenterol Hepatol 2001;13:639-45. [PMID: 11434588 DOI: 10.1097/00042737-200106000-00005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
73 Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995;76:1120-5. [PMID: 8630886 DOI: 10.1002/1097-0142(19951001)76:7<1120::aid-cncr2820760704>3.0.co;2-w] [Cited by in Crossref: 165] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
74 Coia LR, Minsky BD, John MJ, Haller DG, Landry J, Pisansky TM, Willett CG, Hoffman JP, Berkey BA, Owen JB, Hanks GE. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1992-1994 Patterns of Care Study. Cancer 1999;85:2499-505. [DOI: 10.1002/(sici)1097-0142(19990615)85:12<2499::aid-cncr2>3.0.co;2-t] [Cited by in Crossref: 37] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
75 Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients. Ann Surg Oncol 2008;15:104-16. [DOI: 10.1245/s10434-007-9604-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
76 Wei X, Chen Z, Yang X, Wu T, Wu T. Medicinal herbs for esophageal cancer. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd004520.pub5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Thomas CR Jr, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2004;58:1405-1410. [PMID: 15050316 DOI: 10.1016/j.ijrobp.2003.09.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
78 Stone N, Kendall C, Shepherd N, Crow P, Barr H. Near-infrared Raman spectroscopy for the classification of epithelial pre-cancers and cancers. J Raman Spectrosc 2002;33:564-73. [DOI: 10.1002/jrs.882] [Cited by in Crossref: 290] [Cited by in F6Publishing: 201] [Article Influence: 14.5] [Reference Citation Analysis]
79 Conio M, Filiberti R, Blanchi S, Giacosa A. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction. Eur J Cancer Prev 2001;10:483-7. [PMID: 11916346 DOI: 10.1097/00008469-200112000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
80 Mörk H, Scheurlen M, Al-taie O, Zierer A, Kraus M, Schöttker K, Jakob F, Köhrle J. Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus: Glutathione Peroxidases in Barrett's. Int J Cancer 2003;105:300-4. [DOI: 10.1002/ijc.11087] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
81 Guelrud M, Ehrlich EE. Endoscopic classification of Barrett's esophagus. Gastrointestinal Endoscopy 2004;59:58-65. [DOI: 10.1016/s0016-5107(03)02508-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
82 Berg JC. Bird nest deformity of a self-expanding esophageal stent and a technique of removal. Gastrointestinal Endoscopy 1999;50:108-10. [DOI: 10.1016/s0016-5107(99)70358-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
83 Giráldez Jiménez MD. [Which dysplasia screening strategy should be used in patients with Barrett's esophagus?]. Gastroenterol Hepatol 2009;32:162-3. [PMID: 19231034 DOI: 10.1016/j.gastrohep.2008.09.018] [Reference Citation Analysis]
84 Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology. 1998;115:1381-1386. [PMID: 9834265 DOI: 10.1016/s0016-5085(98)70016-2] [Cited by in Crossref: 122] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
85 Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47-56. [PMID: 12512029 DOI: 10.1053/gast.2003.50008] [Cited by in Crossref: 354] [Cited by in F6Publishing: 321] [Article Influence: 18.6] [Reference Citation Analysis]
86 Gao Y, Mclaughlin JK, Blot WJ, Ji B, Benichou J, Dai Q, Fraumeni JF. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192-6. [DOI: 10.1002/ijc.2910580208] [Cited by in Crossref: 122] [Cited by in F6Publishing: 122] [Article Influence: 4.4] [Reference Citation Analysis]
87 Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, Negri E, La Vecchia C. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008;122:1118-1129. [PMID: 17990321 DOI: 10.1002/ijc.23232] [Cited by in Crossref: 145] [Cited by in F6Publishing: 259] [Article Influence: 10.4] [Reference Citation Analysis]
88 Incarbone R, Bonavina L, Szachnowicz S, Saino G, Peracchia A. Rising incidence of esophageal adenocarcinoma in Western countries: is it possible to identify a population at risk? Dis Esophagus. 2000;13:275-278. [PMID: 11284973 DOI: 10.1111/j.1442-2050.2000.00132.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
89 Dresner SM, Griffin SM, Wayman J, Bennett MK, Hayes N, Raimes SA. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia. Br J Surg. 2003;90:1120-1128. [PMID: 12945080 DOI: 10.1002/bjs.4169] [Cited by in Crossref: 96] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
90 Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg. 1999;86:529-535. [PMID: 10215831 DOI: 10.1046/j.1365-2168.1999.01082.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 5.6] [Reference Citation Analysis]
91 Stark SP, Romberg MS, Pierce GE, Hermreck AS, Jewell WR, Moran JF, Cherian G, Delcore R, Thomas JH. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. The American Journal of Surgery 1996;172:478-82. [DOI: 10.1016/s0002-9610(96)00224-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
92 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109. [PMID: 15701501 DOI: 10.1016/j.amjsurg.2004.10.001] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 6.9] [Reference Citation Analysis]
93 Al-kasspooles MF, Hill HC, Nava HR, Smith JL, Douglass HO, Gibbs JF. High-grade dysplasia within Barrett's esophagus: Controversies regarding clinical opinions and approaches. Annals of Surgical Oncology 2002;9:222-7. [DOI: 10.1007/bf02573058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
94 Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales. The American Journal of Gastroenterology 2008;103:2694-9. [DOI: 10.1111/j.1572-0241.2008.02191.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 268] [Article Influence: 12.4] [Reference Citation Analysis]
95 Soontrapornchai P, Elsaleh H, Joseph D, Hamdorf JM, House AK, Iacopetta B. TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value. Eur J Cancer 1999;35:1683-7. [PMID: 10674013 DOI: 10.1016/s0959-8049(99)00172-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
96 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N. En-bloc esophagectomy for esophageal cancer. The American Journal of Surgery 2004;188:254-60. [DOI: 10.1016/j.amjsurg.2004.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
97 Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, Giudicelli R, Fuentes P. Changing patterns and surgical results in adenocarcinoma of the oesophagus: ADENOCARCINOMA OF THE OESOPHAGUS. Br J Surg 1997;84:119-25. [DOI: 10.1046/j.1365-2168.1997.02464.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
98 Demeester TR. Esophageal carcinoma: Current controversies. Semin Surg Oncol 1997;13:217-33. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<217::aid-ssu2>3.0.co;2-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
99 Ribeiro U, Posner MC, Safatle-Ribeiro AV, Reynolds JC. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83:1174-1185. [PMID: 8983603 DOI: 10.1002/bjs.1800830905] [Cited by in Crossref: 89] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
100 Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053. [PMID: 9827707 DOI: 10.1002/(SICI)1097-0142(19981115)83:10%3C2049::AID-CNCR1%3E3.0.CO;2-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
101 Ishimura N, Amano Y, Kinoshita Y. ENDOSCOPIC DEFINITION OF ESOPHAGOGASTRIC JUNCTION FOR DIAGNOSIS OF BARRETT'S ESOPHAGUS: IMPORTANCE OF SYSTEMATIC EDUCATION AND TRAINING. Digestive Endoscopy 2009;21:213-8. [DOI: 10.1111/j.1443-1661.2009.00895.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
102 Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus. Gastrointest Endosc. 2001;54:289-293. [PMID: 11522967 DOI: 10.1067/mge.2001.115728] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 5.1] [Reference Citation Analysis]
103 Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol. 1998;9:951-962. [PMID: 9818067 DOI: 10.1023/A:1008273110272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
104 Mino-kenudson M, Ban S, Ohana M, Puricelli W, Deshpande V, Shimizu M, Nishioka NS, Lauwers GY. Buried Dysplasia and Early Adenocarcinoma Arising in Barrett Esophagus After Porfimer-photodynamic Therapy. American Journal of Surgical Pathology 2007;31:403-9. [DOI: 10.1097/01.pas.0000213407.03064.37] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
105 Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1-17. [PMID: 20676867 DOI: 10.1007/978-3-540-70579-6_1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
106 Lepage C, Drouillard A, Jouve JL, Faivre J. Epidemiology and risk factors for oesophageal adenocarcinoma. Dig Liver Dis. 2013;45:625-629. [PMID: 23453359 DOI: 10.1016/j.dld.2012.12.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
107 Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002;99:860-868. [PMID: 12115489 DOI: 10.1002/ijc.10427] [Cited by in Crossref: 287] [Cited by in F6Publishing: 269] [Article Influence: 14.4] [Reference Citation Analysis]
108 Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus. 2007;20:36-41. [PMID: 17227308 DOI: 10.1111/j.1442-2050.2007.00638.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
109 Sharma P, Bhattacharyya A, Garewal HS, Sampliner RE. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc. 1999;50:159-164. [PMID: 10425406 DOI: 10.1016/S0016-5107(99)70218-X] [Cited by in Crossref: 60] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
110 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
111 Beddow E, Wilcox D, Drake D, Pierro A, Kiely E, Spitz L. Surveillance of Barrett's esophagus in children. Journal of Pediatric Surgery 1999;34:88-91. [DOI: 10.1016/s0022-3468(99)90235-x] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
112 Raman NV, Small W Jr. The Role of Radiation Therapy in the Management of Esophageal Cancer. Cancer Control 1999;6:53-62. [PMID: 10758535 DOI: 10.1177/107327489900600105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
113 Hirayama N, Arima M, Miyazaki S, Shimada H, Okazumi S, Matsubara H, Suzuki T, Ochiai T, Kouzu T. Endoscopic mucosal resection of adenocarcinoma arising in ectopic gastric mucosa in the cervical esophagus: case report. Gastrointestinal Endoscopy 2003;57:263-6. [DOI: 10.1067/mge.2003.84] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
114 Burak WE. Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus? The American Journal of Surgery 2003;186:296-300. [DOI: 10.1016/s0002-9610(03)00222-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 van Sandick JW, van Lanschot JJB, ten Kate FJW, Offerhaus GJA, Fockens P, Tytgat GNJ, Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: Implications for therapeutic decision making. Cancer 2000;88:2429-37. [DOI: 10.1002/1097-0142(20000601)88:11<2429::aid-cncr1>3.0.co;2-h] [Cited by in Crossref: 103] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
116 Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: Results of a Phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83:1908-16. [DOI: 10.1002/(sici)1097-0142(19981101)83:9<1908::aid-cncr5>3.0.co;2-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
117 Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L. Distinction between short-segment Barrett’s esophageal and cardiac intestinal metaplasia. World J Gastroenterol 2005; 11(40): 6360-6365 [PMID: 16419166 DOI: 10.3748/wjg.v11.i40.6360] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
118 Chen KT. Cytology of small-cell carcinoma arising in Barrett's esophagus. Diagn Cytopathol 2000;23:180-2. [PMID: 10945905 DOI: 10.1002/1097-0339(200009)23:3<180::aid-dc7>3.0.co;2-a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
119 Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006;78:236-44. [PMID: 16545878 DOI: 10.1016/j.radonc.2006.01.009] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 7.8] [Reference Citation Analysis]
120 Chen X, Mikhail SS, Ding YW, Yang Gy, Bondoc F, Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis. 2000;21:1531-1536. [PMID: 10910955 DOI: 10.1093/carcin/21.8.1531] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
121 Dellon ES, Shaheen NJ. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol. 2005;23:4478-4482. [PMID: 16002837 DOI: 10.1200/jco.2005.19.059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
122 Casson AG. Role of molecular biology in the follow-up of patients who have Barrett's esophagus. Chest Surgery Clinics of North America 2002;12:93-111. [DOI: 10.1016/s1052-3359(03)00068-1] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
123 Martin DR, Danrad R, Herrmann K, Semelka RC, Hussain SM. Magnetic Resonance Imaging of the Gastrointestinal Tract. Topics in Magnetic Resonance Imaging 2005;16:77-98. [DOI: 10.1097/01.rmr.0000179461.55234.7d] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
124 Becker L, Huang Q, Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett’s esophagus and esophageal adenocarcinoma. Dis Esophagus. 2010;23:168-174. [PMID: 19549212 DOI: 10.1111/j.1442-2050.2009.00979.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
125 O'Reilly S, Forastiere AA. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995;6:519-21. [PMID: 8573528 DOI: 10.1093/oxfordjournals.annonc.a059237] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
126 Poneros JM, Nishioka NS. Diagnosis of Barrett's esophagus using optical coherence tomography. Gastrointestinal Endoscopy Clinics of North America 2003;13:309-23. [DOI: 10.1016/s1052-5157(03)00012-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
127 Kim CY, O’rourke RW, Chang EY, Jobe BA. Unsedated Small-Caliber Upper Endoscopy: An Emerging Diagnostic and Therapeutic Technology. Surg Innov 2006;13:31-9. [DOI: 10.1177/155335060601300106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
128 Altorki NK, Oliveria S, Schrump DS. Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 1997;13:270-80. [PMID: 9229415 DOI: 10.1002/(sici)1098-2388(199707/08)13:4<270::aid-ssu9>3.0.co;2-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
129 Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001;30:1415-1425. [PMID: 11821356 DOI: 10.1093/ije/30.6.1415] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 7.0] [Reference Citation Analysis]
130 Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, Giudicelli R, Fuentes P. Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 1997;84:119-25. [DOI: 10.1002/bjs.1800840143] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
131 Schmidt MK, Meurer L, Volkweis BS, Edelweiss MI, Schirmer CC, Kruel CD, Gurski RR. c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Dis Esophagus 2007;20:212-6. [PMID: 17509117 DOI: 10.1111/j.1442-2050.2007.00673.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
132 Caygill CP, Watson A, Reed PI, Hill MJ. Characteristics and regional variations of patients with Barrett’s oesophagus in the UK. Eur J Gastroenterol Hepatol. 2003;15:1217-1222. [PMID: 14560156 DOI: 10.1097/00042737-200311000-00011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
133 Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Mcginn TG, Wisnivesky JP. Racial Disparities in Esophageal Cancer Treatment and Outcomes. Ann Surg Oncol 2008;15:881-8. [DOI: 10.1245/s10434-007-9664-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
134 Marshall RE, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg. 1997;84:21-28. [PMID: 9043441 DOI: 10.1002/bjs.1800840108] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
135 Ribeiro U, Posner MC, Safatle-Ribeiro AV, Reynolds JC. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996;83:1174-1185. [PMID: 8983603 DOI: 10.1046/j.1365-2168.1996.02421.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
136 Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates: High Survival Rates for Asians with Gastric Carcinoma. Cancer 2000;89:1883-92. [DOI: 10.1002/1097-0142(20001101)89:9<1883::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
137 Arber N, Gammon MD, Hibshoosh H, Britton JA, Zhang Y, Schonberg JB, Roterdam H, Fabian I, Holt PR, Weinstein IB. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Hum Pathol. 1999;30:1087-1092. [PMID: 10492044 DOI: 10.1016/s0046-8177(99)90227-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
138 Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150-155. [PMID: 9450576 DOI: 10.1093/jnci/90.2.150] [Cited by in Crossref: 405] [Cited by in F6Publishing: 360] [Article Influence: 16.9] [Reference Citation Analysis]
139 Mukherjee S, Aston D, Minett M, Brewster A, Crosby T. The Significance of Cardiac Doses Received During Chemoradiation of Oesophageal and Gastro–oesophageal Junctional Cancers. Clinical Oncology 2003;15:115-20. [DOI: 10.1053/clon.2003.0218] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
140 Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 2002;122:633-40. [DOI: 10.1053/gast.2002.31879] [Cited by in Crossref: 366] [Cited by in F6Publishing: 299] [Article Influence: 18.3] [Reference Citation Analysis]
141 Lui VWY, Yau DM, Cheung CS, Wong SCC, Chan AK, Zhou Q, Wong EY, Lau CPY, Lam EKY, Hui EP, Hong B, Hui CWC, Chan AS, Ng PKS, Ng Y, Lo K, Tsang CM, Tsui SKW, Tsao S, Chan ATC. FGF8b oncogene mediates proliferation and invasion of Epstein–Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation. Oncogene 2011;30:1518-30. [DOI: 10.1038/onc.2010.529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
142 Diem M, Stone N, Kendall C, Barr H. Raman Spectroscopy as a Potential Tool for Early Diagnosis of Malignancies in Esophageal and Bladder Tissues. In: Chalmers JM, Griffiths PR, editors. Handbook of Vibrational Spectroscopy. Chichester: John Wiley & Sons, Ltd; 2006. [DOI: 10.1002/0470027320.s8931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
143 Umansky M, Yasui W, Hallak A, Brill S, Shapira I, Halpern Z, Hibshoosh H, Rattan J, Meltzer S, Tahara E. Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. Oncogene. 2001;20:7987-7991. [PMID: 11753681 DOI: 10.1038/sj.onc.1204947] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
144 Demeester SR, Peters JH, Demeester TR. Barrett’s esophagus. Curr Probl Surg. 2001;38:558-640. [PMID: 11468640 DOI: 10.1067/msg.2001.115514] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
145 Sánchez-Fayos P, Martín MJ, González A, Bosch O, Polo B, Arocena C, Porres JC. [Barrett's esophagus: the biological reality of a premaligmant columnar metaplasia]. Gastroenterol Hepatol 2002;25:254-66. [PMID: 11975875 DOI: 10.1016/s0210-5705(02)70256-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
146 Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A. CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol. 2005;29:390-399. [PMID: 15725809 DOI: 10.1097/00000478-200503000-00014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
147 Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;69:225-35. [PMID: 8682592 DOI: 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6] [Cited by in Crossref: 185] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
148 Harbord M, Dawes RF, Barr H, Giovannini M, Viens P, Eysselein V, Mishra L, Orenberg EK, Bown SG. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointestinal Endoscopy 2002;56:644-51. [DOI: 10.1016/s0016-5107(02)70111-9] [Cited by in Crossref: 22] [Article Influence: 1.1] [Reference Citation Analysis]
149 Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001;120:7-12. [PMID: 11208708 DOI: 10.1053/gast.2001.20911] [Cited by in Crossref: 204] [Cited by in F6Publishing: 174] [Article Influence: 9.7] [Reference Citation Analysis]
150 Geh JI, Glynne-Jones R, Kwok QS, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma. Clin Oncol (R Coll Radiol) 2000;12:182-7. [PMID: 10942336 DOI: 10.1053/clon.2000.9147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.0] [Reference Citation Analysis]
151 Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry. Am J Clin Oncol 2009;32:286-90. [PMID: 19433959 DOI: 10.1097/COC.0b013e31818af0d8] [Reference Citation Analysis]
152 Pera M, Pera M. Recent changes in the epidemiology of esophageal cancer. Surg Oncol 2001;10:81-90. [PMID: 11750227 DOI: 10.1016/s0960-7404(01)00025-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
153 Lepage C, Bouvier A, Manfredi S, Coatmeur O, Cheynel N, Faivre J. Trends in incidence and management of esophageal adenocarcinoma in a well-defined population. Gastroentérologie Clinique et Biologique 2005;29:1258-63. [DOI: 10.1016/s0399-8320(05)82218-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 Amonkar MM, Kalsekar ID, Boyer JG. The economic burden of Barrett's esophagus in a Medicaid population. Ann Pharmacother 2002;36:605-11. [PMID: 11918506 DOI: 10.1345/aph.1A309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
155 Greenstein AJ, Wisnivesky JP, Litle VR. Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Dis Esophagus 2008;21:673-8. [PMID: 18459986 DOI: 10.1111/j.1442-2050.2008.00832.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
156 Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95:1434-1443. [PMID: 12237911 DOI: 10.1002/cncr.10868] [Cited by in Crossref: 283] [Cited by in F6Publishing: 263] [Article Influence: 14.2] [Reference Citation Analysis]
157 Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br J Surg. 2001;88:1357-1362. [PMID: 11578292 DOI: 10.1046/j.0007-1323.2001.01926.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
158 Guelrud M, Ehrlich EE. Enhanced magnification endoscopy in the upper gastrointestinal tract. Gastrointest Endosc Clin N Am. 2004;14:461-473, viii. [PMID: 15261196 DOI: 10.1016/j.giec.2004.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
159 Lin OS, Mannava S, Hwang KL, Triadafilopoulos G. Reasons for current practices in managing Barrett's esophagus. Dis Esophagus 2002;15:39-45. [PMID: 12060041 DOI: 10.1046/j.1442-2050.2002.00221.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
160 Wright CD, Mathisen DJ, Wain JC, Grillo HC, Hilgenberg AD, Moncure AC, Carey RW, Choi NC, Daly M, Logan DL. Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. The Annals of Thoracic Surgery 1994;58:1574-9. [DOI: 10.1016/0003-4975(94)91635-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
161 Ellis FH, Xu X, Kulke MH, LoCicero J, Loda M. Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice. J Thorac Cardiovasc Surg. 2001;122:809-814. [PMID: 11581618 DOI: 10.1067/mtc.2001.116471] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]